23andMe Files for Chapter 11 Bankruptcy; CEO Resigns to Pursue Independent Bid

Genetic testing company 23andMe has filed for Chapter 11 bankruptcy protection in a move aimed at restructuring operations and facilitating a court-supervised asset sale. Co-founder Anne Wojcicki has stepped down as CEO to position herself as an independent bidder for the company’s assets. The filing follows ongoing financial challenges, a major 2023 data breach, and shifts in the consumer health tech space.